Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$942K Buy
2,602
+104
+4% +$35.6K 0.16% 161
2026
Q1
$879K Sell
2,498
-40
-2% -$14.3K 0.17% 150
2025
Q4
$831K Sell
2,538
-476
-16% -$151K 0.17% 147
2025
Q3
$858K Buy
3,014
+472
+19% +$137K 0.2% 123
2025
Q2
$716K Sell
2,542
-1,789
-41% -$507K 0.13% 158
2025
Q1
$1.24M Buy
4,331
+1,938
+81% +$572K 0.07% 260
2024
Q4
$659K Buy
+2,393
New +$710K 0.18% 126

Other funds holding AMGN

GWN Securities's AMGN Position: Q2 2026 in Review

GWN Securities increased its Amgen (AMGN) stake by 4.2% in Q2 2026, buying an estimated $35.6K and bringing the position to 2,602 shares worth $942K. The position accounts for 0.16% of the portfolio, ranked #161.

GWN Securities first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.24M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GWN Securities held 2,602 shares of Amgen worth $942K as of Q2 2026.
  • GWN Securities bought 104 Amgen shares in Q2 2026, an estimated $35.6K.
  • Amgen made up 0.16% of GWN Securities's portfolio in Q2 2026, its #161 holding.
  • GWN Securities first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Amgen position peaked at $1.24M in Q1 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.